Results 111 to 120 of about 2,620,097 (300)

Class IIa HDACs forced degradation allows resensitization of oxaliplatin‐resistant FBXW7‐mutated colorectal cancer

open access: yesMolecular Oncology, EarlyView.
HDAC4 is degraded by the E3 ligase FBXW7. In colorectal cancer, FBXW7 mutations prevent HDAC4 degradation, leading to oxaliplatin resistance. Forced degradation of HDAC4 using a PROTAC compound restores drug sensitivity by resetting the super‐enhancer landscape, reprogramming the epigenetic state of FBXW7‐mutated cells to resemble oxaliplatin ...
Vanessa Tolotto   +13 more
wiley   +1 more source

Acidentes de trânsito no Brasil: dados e tendências

open access: yesCadernos de Saúde Pública
As estatísticas de mortalidade mostram, em 1988, para o Brasil, que cerca de 12% dos óbitos são devidos a causas externas, e destes 30% são por acidentes de trânsito. Quando se comparam com outros países, os dados referentes ao Brasil são sempre elevados.
Maria Helena P. de Mello Jorge   +1 more
doaj  

Mortalidad por causas accidentales en niños menores de 5 años en el Hospital Nacional de Niños "Dr. Carlos Sáenz Herrera", 2002-2004 Mortality due to accidental causes in children younger than 5 years of age at the Hospital Nacional de Niños "Dr. Carlos Sáenz Herrera", 2002-2004

open access: yesActa Médica Costarricense, 2008
Las lesiones traumáticas por causas externas corresponden en Costa Rica a la segunda causa de muerte en niños menores de 5 años, con una tasa para 2004 de 9.23 x 100000 habitantes, y la primera causa de años de vida potencialmente perdidos (37%) para ...
Adriana Benavides-Lara   +1 more
doaj  

Infant mortality in Brazil from 2000 to 2020: a study of spatial and trend analysis

open access: yesBMC Public Health
Background The Infant Mortality Rate assesses the deaths occurring in children under one year of age and serves as an important health indicator in mapping the living conditions of a given society.
Tainara Lorena dos Santos Ferreira   +4 more
doaj   +1 more source

Cis‐regulatory and long noncoding RNA alterations in breast cancer – current insights, biomarker utility, and the critical need for functional validation

open access: yesMolecular Oncology, EarlyView.
The noncoding region of the genome plays a key role in regulating gene expression, and mutations within these regions are capable of altering it. Researchers have identified multiple functional noncoding mutations associated with increased cancer risk in the genome of breast cancer patients.
Arnau Cuy Saqués   +3 more
wiley   +1 more source

Strength through diversity: how cancers thrive when clones cooperate

open access: yesMolecular Oncology, EarlyView.
Intratumor heterogeneity can offer direct benefits to the tumor through cooperation between different clones. In this review, Kuiken et al. discuss existing evidence for clonal cooperativity to identify overarching principles, and highlight how novel technological developments could address remaining open questions.
Marije C. Kuiken   +3 more
wiley   +1 more source

Home - About - Disclaimer - Privacy